文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

重症急性胰腺炎合并肾功能亢进患者万古霉素的PK/PD

[PK/PD of vancomycin in patients with severe acute pancreatitis combined with augmented renal clearance].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2017-01-01
一句话结论重症急性胰腺炎合并肾功能亢进患者万古霉素稳态谷浓度显著降低,24小时连续输注可优化PK/PD参数并降低日剂量。

该回顾性研究纳入2011年1月至2016年12月上海交通大学医学院附属瑞金医院急诊重症监护病房(EICU)收治的接受万古霉素治疗的重症急性胰腺炎(SAP)住院患者61例,收集万古霉素稳态谷浓度。结果显示SAP患者平均稳态谷浓度为(7.7±4.4)mg/L,显著低于标准浓度15 mg/L(P<0.001);表观分布容积为(1.06±0.26)L/kg,清除率为(8.9±2.8)L/h。肾功能亢进(ARC)组稳态谷浓度显著低于非ARC组(6.7±3.5 vs. 8.2±4.1 mg/L,P<0.01),清除率显著升高(9.8±2.9 vs. 7.7±2.2 L/h,P<0.01);全身炎症反应综合征(SIRS)组稳态谷浓度显著低于非SIRS组(6.1±3.2 vs. 13.0±4.2 mg/L,P<0.01),清除率显著升高(9.4±2.0 vs. 7.1±2.1 L/h,P<0.05)。与仅增加万古霉素剂量组(n=29)相比,万古霉素24小时连续输注组(n=21)可显著降低日剂量(13.6±3.9 vs. 19.1±3.5 mg/kg,P<0.01),提高血清谷浓度(18.1±7.0 vs. 12.6±5.3 mg/L,P<0.01),并改善AUCc-t/MIC。结论认为SAP合并ARC患者万古霉素谷浓度显著降低,SIRS越严重谷浓度越低,24小时连续输注可优化PK/PD参数、降低日

要点

  • SAP患者万古霉素平均稳态谷浓度为(7.7±4.4)mg/L,显著低于标准浓度15 mg/L(P<0.001)。
  • ARC组万古霉素稳态谷浓度显著低于非ARC组(6.7±3.5 vs. 8.2±4.1 mg/L,P<0.01),清除率显著升高(9.8±2.9 vs. 7.7±2.2 L/h,P<0.01)。
  • SIRS组万古霉素稳态谷浓度显著低于非SIRS组(6.1±3.2 vs. 13.0±4.2 mg/L,P<0.01),清除率显著升高(9.4±2.0 vs. 7.1±2.1 L/h,P<0.05)。
  • 与仅增加剂量组相比,万古霉素24小时连续输注组日剂量显著降低(13.6±3.9 vs. 19.1±3.5 mg/kg,P<0.01),血清谷浓度显著提高(18.1±7.0 vs. 12.6±5.3 mg/L,P<0.01),并改善AUCc-t/MIC。

适用人群与场景

  • 2011年1月至2016年12月上海交通大学医学院附属瑞金医院急诊重症监护病房(EICU)收治的接受万古霉素治疗的重症急性胰腺炎(SAP)住院患者。

诊断标准与关键阈值

  • 根据患者有无肾功能亢进(ARC)症状分为ARC组与非ARC组。
  • 根据患者有无全身炎症反应综合征(SIRS)症状分为SIRS组与非SIRS组。
  • 万古霉素稳态谷浓度低于目标水平时,进行调整:增加剂量、24小时连续输注或增加万古霉素剂量。

处置流程与药物剂量

  • 万古霉素稳态谷浓度低于目标水平时,调整方案包括增加剂量、24小时连续输注或增加万古霉素剂量。
  • 万古霉素24小时连续输注可显著降低日剂量(13.6±3.9 vs. 19.1±3.5 mg/kg,P<0.01),提高血清谷浓度(18.1±7.0 vs. 12.6±5.3 mg/L,P<0.01),并改善AUCc-t/MIC。

研究设计与关键结果

  • 研究类型为回顾性研究,纳入61例SAP患者,收集万古霉素稳态谷浓度或稳态浓度,平均稳态谷浓度为(7.7±4.4)mg/L,显著低于标准浓度15 mg/L(P<0.001)。
  • 万古霉素表观分布容积(Vd)为(1.06±0.26)L/kg,清除率为(8.9±2.8)L/h。
  • ARC组(n=33)万古霉素血清稳态谷浓度显著低于非ARC组(n=28;6.7±3.5 vs. 8.2±4.1 mg/L,P<0.01),清除率显著升高(9.8±2.9 vs. 7.7±2.2 L/h,P<0.01)。
  • SIRS组(n=30)万古霉素血清稳态谷浓度显著低于非SIRS组(n=31;6.1±3.2 vs. 13.0±4.2 mg/L,P<0.01),清除率显著升高(9.4±2.0 vs. 7.1±2.1 L/h,P<0.05)。
  • 与仅增加万古霉素剂量组(n=29)相比,万古霉素24小时连续输注组(n=21)可显著降低日剂量(13.6±3.9 vs. 19.1±3.5 mg/kg,P<0.01),提高血清谷浓度(18.1±7.0 vs. 12.6±5.3 mg/L,P<0.01),并改善AUCc-t/MIC。

证据类型、等级与局限

  • 证据类型:回顾性研究。

对床旁实践的改变

  • SAP合并ARC患者万古霉素血清谷浓度显著降低,SIRS越严重谷浓度越低。
  • 万古霉素24小时连续输注可优化PK/PD参数,降低日剂量,提高临床疗效,减少细菌耐药。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the serum trough concentration and the pharmacokinetics/pharmacodynamics (PK/PD) of vancomycin in patients with severe acute pancreatitis (SAP), and analyze the effect of vancomycin continuous infusion for optimizing the characteristics of its PK/PD.

METHODS: The inhospital patients with SAP received vancomycin treatment and admitted to emergency intensive care unit (EICU) of Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine from January 2011 to December 2016 were enrolled. Steady-state trough concentrations of vancomycin from patients were collected retrospectively. The SAP patients were divided into augmented renal clearance (ARC) and non-ARC groups, as well as systemic inflammatory response syndrome (SIRS) and non-SIRS groups according to the patients with or without symptom above. Adjustments of increased dosage or 24-hour continuous infusion or increase vancomycin dose were made for patients if the steady-state trough concentrations fell below the target level. Steady state trough concentration for vancomycin intermittent infusion or steady state concentration for vancomycin continuous infusion was determined by the fluorescence polarization immunoassay method. PK parameters of vancomycin were calculated using the Bayesian estimator and the area under the serum drug concentration-time curve (AUCc-t), the minimum inhibitory concentration (MIC) and AUCc-t/MIC was recorded and calculated.

RESULTS: The steady state trough concentration or steady state concentration from 61 patients with SAP were collected with mean steady state trough concentration of vancomycin of (7.7±4.4) mg/L, which was significantly lower than standard concentration (15 mg/L, P < 0.001). Apparent volume of distribution (Vd) and clearance of vancomycin was (1.06±0.26) L/kg and (8.9±2.8) L/h. The serum steady state trough concentration of vancomycin in ARC group (n = 33) was significantly lower than that in non-ARC group (n = 28; mg/L: 6.7±3.5 vs. 8.2±4.1, P < 0.01), clearance was significantly increased (L/h: 9.8±2.9 vs. 7.7±2.2, P < 0.01). Compared with non-SIRS group (n = 31), the serum steady state trough concentration of vancomycin in SIRS group (n = 30) was significantly lowered (mg/L: 6.1±3.2 vs. 13.0±4.2, P < 0.01), and clearance was significantly increased (L/h: 9.4±2.0 vs. 7.1±2.1, P < 0.05). Compared with the only increasing vancomycin dose group (n = 29), vancomycin continuous infusion for 24 hours (n = 21) could significantly reduce daily dosage (mg/kg: 13.6±3.9 vs. 19.1±3.5, P < 0.01), increase the serum trough concentration (mg/L: 18.1±7.0 vs. 12.6±5.3, P < 0.01), and improve the AUCc-t/MIC.

CONCLUSIONS: The serum trough concentration of vancomycin was significantly reduced in SAP patients with ARC. The more serious of the SIRS is, the lower the vancomycin trough concentration is. Vancomycin 24-hour continuous infusion could optimize the PK/PD parameters, decrease the daily dose, increase the clinical effect, and reduce the bacterial resistance.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. He J, Mao E, Jing F, et al. [PK/PD of vancomycin in patients with severe acute pancreatitis combined with augmented renal clearance]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 28936957. doi:10.3760/cma.j.issn.2095-4352.2017.09.009

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。